During the past decade, Virtual metasite conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Virtual metasite" are "COVID-19" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Fertility Issues" (1 trials) and "Fertility Risk" (1 trials). Many other conditions were trialed in "Virtual metasite" in a lesser frequency.

Most popular intervention types in "Virtual metasite" are "Device" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Transvaginal ultrasound performed by a woman herself (with HCP supervision via telemedicine)" (2 trials), "Continuous Glucose Monitoring" (1 trials), "Insulin Lispro" (1 trials), "Placebo" (1 trials) and "Rivaroxaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virtual metasite" are 3 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Virtual metasite". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Virtual metasite, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Virtual metasite, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".